
Industry News
New Zealand company collaborates on FDA approval of a novel treatment for river blindness
Argenta Limited, a New Zealand animal health company, has worked with Medicines Development for Global Health (MDGH), a not-for-profit Australian biopharmaceutical company, to gain US Federal Drug Administration (FDA) approval of an innovative treatment for river blindness. Approved by the FDA to
June 28, 2018